|
Effect of Olivomed (Olive Extract) on Endothelial, Cardiac and Vascular Function
RECRUITINGN/ASponsored by University of Athens
Actively Recruiting
PhaseN/A
SponsorUniversity of Athens
Started2020-12-01
Est. completion2025-04-10
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04520126
Summary
Olive extracts are considered to have antioxidant properties. The investigators will study the effect of olive extracts containing hydroxytyrosol (HT)-olivomed and combination of Oleuropein (OL), Hydroxytyrosol (HT), Oleocanthal (OC) - olivomedSmart on endothelial, cardiac and vascular function in patients with coronary artery disease .
Eligibility
Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria: 1. Age \<70 years 2. Stable coronary heart disease 3. Patients with acute coronary syndrome who have undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG), 2 months must have passed since the incident 4. High LDL levels, low HDL, high triglycerides Exclusion Criteria: 1. Age\> 70 years 2. Patient with diabetes 3. Patient with hypertension 4. Patient with liver disease 5. Patient with thyroid disease 6. Patient with active malignancy 7. Patient with a disease that affects inflammatory markers (rheumatic diseases, etc.) 8. Patient with chronic renal failure (creatinine\> 2 mg / dl) 9. Patient treated chronically with corticosteroids 10. Patient who has joined a weight loss program or any dietary intervention or intensive exercise programme within the previous 2 months or consumes multivitamin preparations with antioxidant properties.
Conditions2
Coronary Artery DiseaseHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Athens
Started2020-12-01
Est. completion2025-04-10
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04520126